Menu
Back to User profile » Dr Rishi P Singh
Papers published by Dr Rishi P Singh:
Angiopoietins as Potential Targets in Management of Retinal Disease
Khanani AM, Russell MW, Aziz AA, Danzig CJ, Weng CY, Eichenbaum DA, Singh RP
Clinical Ophthalmology 2021, 15:3747-3755
Published Date: 4 September 2021
Photobiomodulation Therapy for Age-Related Macular Degeneration and Diabetic Retinopathy: A Review
Muste JC, Russell MW, Singh RP
Clinical Ophthalmology 2021, 15:3709-3720
Published Date: 2 September 2021
Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies
Singh RP, Staurenghi G, Pollack A, Adewale A, Walker TM, Sager D, Lehmann R
Clinical Ophthalmology 2017, 11:1021-1029
Published Date: 29 May 2017
A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum]
Singh RP, Srivastava SK, Ehlers JP, Silva FQ, Bedi R, Schachat AP, Kaiser PK
Clinical Ophthalmology 2017, 11:303-304
Published Date: 7 February 2017
A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis
Singh RP, Srivastava SK, Ehlers JP, Silva FQ, Bedi R, Schachat AP, Kaiser PK
Clinical Ophthalmology 2015, 9:1759-1766
Published Date: 22 September 2015
Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy
Singh R, Alpern L, Jaffe GJ, Lehmann RP, Lim J, Reiser HJ, Sall K, Walters T, Sager D
Clinical Ophthalmology 2012, 6:1259-1269
Published Date: 3 August 2012